PPARG and metabolic dysfunction-associated steatotic liver disease: NAFLD models of mice rendered deficient in hepatocyte-specific PPARγ had reduced hepatic steatosis relative to PPARγ-intact counterparts, whereas adipose tissue-specific PPARγ knockout mice were lipodystrophy but associated with fatty liver.